Male Hypogonadism: How to Prep for Your First Visit

Why Your First Visit Matters More Than Any Subsequent One

The first appointment sets the diagnostic trajectory. Arriving unprepared means your physician may order a single afternoon testosterone draw, miss a secondary cause, or defer treatment because the paperwork is incomplete. One properly timed lab visit paired with a clear symptom narrative can compress what often takes three to four appointments into one.

The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism states: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone levels." [1] That two-part requirement, biochemical and symptomatic, means you need to prepare evidence on both fronts.

The Scope of the Problem

Male hypogonadism affects an estimated 2 to 6% of men overall, with prevalence rising to roughly 20% in men over 60. [2] The condition is underdiagnosed partly because symptoms overlap with normal aging, depression, and metabolic disease. Knowing the specific criteria before you walk in puts you ahead of most patients.

Step 1: Get the Right Blood Work Before Your Appointment

Timing Is Everything

Testosterone follows a circadian rhythm. Serum levels peak between 7:00 and 10:00 AM and can fall 20 to 35% by early afternoon in younger men. [3] A 2:00 PM draw in a fatigued 45-year-old can produce a falsely low result that triggers unnecessary treatment, or a borderline result that delays a necessary one.

Book your lab for the earliest available morning slot. Fasting is not strictly required, but a heavy carbohydrate meal acutely suppresses testosterone by up to 25% through insulin-mediated SHBG reduction, so keep breakfast light. [4]

Which Labs to Request

Ask your primary care provider or the ordering clinician to include all of the following on the requisition:

• Total testosterone (the primary screening test)
• Free testosterone (calculated or equilibrium dialysis; essential if SHBG is suspected to be abnormal)
• Sex hormone-binding globulin (SHBG)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (distinguish primary from secondary hypogonadism)
• Prolactin (elevated prolactin points toward a pituitary adenoma)
• Complete blood count (CBC) (baseline hematocrit before any testosterone therapy)
• Comprehensive metabolic panel (CMP)
• PSA (prostate-specific antigen) for men 40 and older
• Thyroid-stimulating hormone (TSH) (thyroid dysfunction mimics many hypogonadism symptoms)
• Vitamin D (deficiency is common and compounds fatigue and mood symptoms)

A study published in the Journal of Clinical Endocrinology and Metabolism found that free testosterone reclassified hypogonadal status in 30% of men whose total testosterone was borderline (300 to 400 ng/dL), particularly those with obesity or liver disease that alters SHBG. [5]

Why Two Draws Are Required

The Endocrine Society and the American Urological Association both require confirmation on a second morning sample before diagnosis. [1] Biological variability alone can shift total testosterone by 10 to 15% between draws. Two below-threshold results on separate mornings reduce the false-positive rate substantially. Schedule your second draw at least 24 hours after the first, ideally within one to two weeks.

Step 2: Build a Symptom Log You Can Hand to Your Doctor

The Core Symptoms

The Endocrine Society lists the following as "more specific" symptoms of androgen deficiency: [1]

• Incomplete or delayed sexual development (if onset is pre-pubertal)
• Reduced libido and sexual activity
• Decreased spontaneous erections
• Breast discomfort or gynecomastia
• Loss of body and facial hair
• Small testes or testicular atrophy
• Infertility or low sperm count
• Height loss, low-trauma fracture, or low bone density

Less specific but commonly reported symptoms include fatigue, depressed mood, poor concentration, disturbed sleep, and reduced physical performance.

How to Structure Your Log

Write down three things for each symptom: when it started (month and year if possible), its severity on a 1 to 10 scale, and whether anything makes it better or worse. A two-week prospective diary before your appointment is worth more than a retroactive guess on the day of the visit.

The Androgen Deficiency in Aging Males (ADAM) questionnaire is a validated 10-question tool you can print and complete at home. [6] A score that is positive on questions 1 or 7 (low libido or low energy) plus three others carries a sensitivity of 88% for hypogonadism. Bring a completed copy to hand directly to your provider.

Lifestyle Factors That Suppress Testosterone

Your doctor will ask about these. Document them honestly:

• Sleep: chronic sleep restriction to 5 hours reduces testosterone by 10 to 15% compared to 8 hours. [7]
• Weight: each 1-point increase in BMI reduces testosterone by approximately 2%. [8]
• Alcohol: heavy use (more than 3 drinks daily) suppresses the hypothalamic-pituitary-gonadal axis.
• Opioids: long-term use causes opioid-induced androgen deficiency in up to 74% of men. [9]
• Anabolic steroids: prior use suppresses the HPG axis for months to years.

Step 3: Compile Your Medical and Medication History

Conditions That Cause or Mimic Hypogonadism

Several common diagnoses directly lower testosterone or produce overlapping symptoms. Flag any of the following in your history:

• Type 2 diabetes: Men with T2D have a 2-fold higher prevalence of hypogonadism. [10]
• Obesity (BMI >30): Adipose tissue converts testosterone to estradiol via aromatase.
• Obstructive sleep apnea: Treating OSA with CPAP raises morning testosterone by an average of 72 ng/dL in one meta-analysis. [11]
• Hemochromatosis: Iron overload damages both the testes and the pituitary.
• Prior chemotherapy or radiation: Both cause primary testicular failure.
• Klinefelter syndrome (47,XXY): The most common genetic cause of primary hypogonadism.
• Pituitary tumors or surgery: Disrupt gonadotropin secretion.

Medications That Lower Testosterone

Bring a complete medication list, including over-the-counter products and supplements. These drug classes are known suppressors: [12]

• Opioid analgesics (morphine, oxycodone, fentanyl, methadone)
• Glucocorticoids (prednisone, dexamethasone)
• Ketoconazole
• Spironolactone
• GnRH agonists (leuprolide, goserelin)
• 5-alpha reductase inhibitors (finasteride, dutasteride), these reduce DHT and can worsen symptoms
• Some antidepressants and antipsychotics

Step 4: Understand the Diagnostic Framework Before You Walk In

The diagnostic process your physician follows maps onto a two-axis grid. The first axis is biochemical severity (how low is total and free testosterone). The second is symptom burden (how many symptoms, how severe). Treatment decisions shift depending on where you land.

Axis 1: Biochemical Thresholds

| Testosterone Level | Classification | |---|---| | <300 ng/dL (total T) | Below Endocrine Society threshold [1] | | <264 ng/dL (total T) | Below CDC harmonized reference cutoff [13] | | <9 ng/dL (free T, calculated) | Consistent with deficiency per many labs | | 300 to 400 ng/dL (total T) | Borderline; free T and symptoms determine next step |

Axis 2: Symptom Burden Scoring

Use the Aging Males' Symptoms (AMS) scale. [14] Scores above 37 indicate moderate-to-severe symptom burden and support treatment even when total testosterone is in the 300 to 400 ng/dL borderline zone, particularly if free testosterone is low.

Classifying Primary vs. Secondary Hypogonadism

Your LH and FSH results tell the story:

• Primary (hypergonadotropic) hypogonadism: LH and FSH are high because the pituitary is signaling correctly but the testes are not responding. Causes include Klinefelter syndrome, orchitis, prior chemotherapy.
• Secondary (hypogonadotropic) hypogonadism: LH and FSH are low or inappropriately normal. Causes include pituitary adenoma, hyperprolactinemia, obesity, opioid use, and hypothalamic dysfunction.

This distinction is not academic. Secondary hypogonadism caused by a prolactinoma may resolve completely with dopamine agonist therapy (cabergoline 0.5 to 2 mg weekly) rather than testosterone. [15]

Step 5: Know the Treatment Field Before Your Appointment

You do not need to arrive having chosen a treatment. You do need to arrive knowing enough to ask productive questions. Your physician will weigh your symptom burden, testosterone levels, fertility goals, cardiovascular risk, and personal preferences.

Testosterone Replacement Therapy Options

Topical gels and solutions (e.g., AndroGel 1.62%, Testim, Natesto) deliver testosterone transdermally once daily. Absorption varies by 20 to 30% between individuals. Transfer to partners or children is a real risk if skin contact occurs before the gel dries.

Injectable testosterone (testosterone cypionate or enanthate, 100 to 200 mg every 1 to 2 weeks; or testosterone undecanoate, 750 mg IM every 10 weeks after loading) produces higher peak-to-trough variability with shorter-acting esters but is cost-effective and widely available. [16]

Subcutaneous pellets (Testopel, 150 to 450 mg, inserted every 3 to 6 months) provide the most stable serum levels but require a minor in-office procedure.

Nasal gel (Natesto 11 mg three times daily) avoids skin transfer risk and may preserve intratesticular testosterone production better than other routes, though long-term comparative data are limited.

The TRAVERSE Trial: What It Means for Your Safety Discussion

The 2023 TRAVERSE trial (N=5,246) found that testosterone replacement therapy in men with hypogonadism and high cardiovascular risk did not significantly increase the rate of major adverse cardiac events compared to placebo (hazard ratio 0.96, 95% CI 0.78 to 1.17). [17] This was a landmark finding after years of cardiovascular uncertainty. Your physician may reference it when discussing risk. Ask specifically whether your cardiovascular risk profile resembles the TRAVERSE population (mean age 63, mean baseline testosterone 227 ng/dL, established or high-risk cardiovascular disease).

The trial also found a higher incidence of atrial fibrillation (3.5% vs. 2.4%) and pulmonary embolism (0.9% vs. 0.5%) in the testosterone arm. These are real signals that belong in the informed-consent conversation.

Alternatives to Testosterone for Secondary Hypogonadism

If your LH and FSH are low and fertility preservation matters to you, several alternatives exist:

• Clomiphene citrate 25 to 50 mg every other day or daily: A selective estrogen receptor modulator that stimulates pituitary LH and FSH secretion, raising intratesticular testosterone. Not FDA-approved for this indication but widely used off-label. [18]
• hCG (human chorionic gonadotropin): Mimics LH and stimulates testicular testosterone production while preserving spermatogenesis. Often combined with FSH analogs when fertility is the primary goal.
• Enclomiphene citrate: The active (trans) isomer of clomiphene, under regulatory review for male hypogonadism at the time of writing.

Step 6: Questions to Ask Your Doctor

Walking in with written questions signals to your provider that you are an active participant and often results in a more thorough visit. The following are specific, clinically useful questions to raise:

1. "My testosterone was drawn at 2 PM last time. Can we recheck it at 8 AM on two separate mornings before deciding?"
2. "My LH and FSH are low. Does that change whether I need an MRI of my pituitary before starting treatment?"
3. "I want to preserve fertility. What happens to sperm production if I start testosterone, and how long does it take to recover if I stop?"
4. "My hematocrit is already 47%. What threshold would you use to pause or adjust treatment?"
5. "What is my PSA now, and how often will you check it after starting testosterone?"
6. "Is there a reversible cause here, like sleep apnea or a medication, that we should address first?"

Step 7: What Happens After the Visit

Monitoring Schedule

The Endocrine Society recommends checking testosterone, hematocrit, and PSA at 3 to 6 months after starting therapy and annually thereafter. [1] Bone density (DEXA scan) is recommended at baseline if fracture risk is elevated.

Hematocrit above 54% is a threshold most clinicians use to pause therapy, reduce dose, or switch route of administration. [1] Red cell mass increases because testosterone stimulates erythropoiesis. This is the most common adverse effect requiring dose adjustment.

Setting Realistic Expectations

Sexual desire and mood typically respond within 3 to 6 weeks of reaching target testosterone levels (generally 400 to 700 ng/dL total testosterone). Body composition changes, specifically lean mass gain and fat mass reduction, take 3 to 6 months and are accelerated by resistance training. Bone mineral density response requires 12 to 24 months to manifest on DEXA. [19]

A meta-analysis of 51 randomized controlled trials (N=4,835) published in JAMA Internal Medicine found statistically significant improvements in sexual function, depressive symptoms, and bone density with testosterone therapy, with modest and variable effects on physical performance and cognitive function. [20] The effect size on sexual function (standardized mean difference 0.63) was larger than on any other outcome.

The average man starting therapy who does not also address sleep, resistance training, and metabolic health will see partial results. Testosterone is one variable in a larger equation.